Medicare’s obesity-drug program requires a body mass index of 35, or 30 with heart failure, uncontrolled blood pressure or kidney disease.
Not every Medicare beneficiary who wants help losing weight qualifies for the new $50-a-month GLP-1 drug program, even if a doctor thinks it would help. Medicare GLP-1 Bridge, which began July 1, 2026, sets eligibility by body mass index, but not a single cutoff line; it uses three separate BMI thresholds, each paired with its…